---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/42186669.md"
description: "$Pulsenmore(PLSM.US) surged +93% in a single day, catalyzed by being selected by Ouma Health, a leading U.S. maternity and postpartum telemedicine platform, as the home ultrasound entry point, and FDA approval has also been granted. The story itself is true.The question is, for such a micro-cap medical device stock, can a partnership with one major client support a doubled valuation, or will the sentiment be exhausted in just a few days? The latter is more likely — there's a long gap between a single partnership landing and actual revenue realization. Those without positions shouldn't FOMO buy on this +93% day 🙈"
datetime: "2026-06-25T10:39:59.000Z"
locales:
  - [en](https://longbridge.com/en/topics/42186669.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/42186669.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/42186669.md)
author: "[这个世界需要英雄](https://longbridge.com/en/profiles/27713130.md)"
generator: "portal-rs"
---

# $Pulsenmore(PLSM.US) surged +93% in a single day, …


### Related Stocks

- [PLSM.US](https://longbridge.com/en/quote/PLSM.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**